Suchergebnisse - "Cervantes, A"

PubPharm (442)

11

In the literature : May 2023

enthalten in: ESMO open | 2023

von Gambardella, V. | Cejalvo, J. | Cervantes, A.

12

The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial

enthalten in: ESMO open | 2023

von Dijkstra, E. | Zwart, W. | Nilsson, P. | +18

13

Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer

enthalten in: ESMO open | 2023

von Rudin, C. | Cervantes, A. | Dowlati, A. | +11

14

FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer

enthalten in: ESMO open | 2023

von Cervantes, A. | Prager, G.

15

In the Literature : March 2023

enthalten in: ESMO open | 2023

von Gambardella, V. | Tarazona, N. | Roda, D. | +1

16

In the Literature : January 2023

enthalten in: ESMO open | 2023

von Martín-Arana, J. | Gambardella, V. | Tarazona, N. | +2

17

Metastatic colorectal cancer : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Cervantes, A. | Adam, R. | Roselló, S. | +9

18

In the literature : November 2022

enthalten in: ESMO open | 2022

von Gambardella, V. | Cejalvo, J. | Cervantes, A.

19

ESMO Expert Consensus Statements on Cancer Survivorship : promoting high-quality survivorship care and research in Europe

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Vaz-Luis, I. | Masiero, M. | Cavaletti, G. | +25

20

Oesophageal cancer : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Obermannová, R. | Alsina, M. | Cervantes, A. | +7

CommentIn: Ann Oncol. 2023 Jun;34(6):553-554. - PMID 36965575